Background and Aim: Endoscopic balloon dilatation (EBD) has been used for the treatment of gastric outlet obstruction (GOO). There are several reports on the utility and success of this non ...

The Chinese balloon that sparked panic when it flew over the US two years ago was, as long suspected, set up to spy on Americans — but surprisingly with US-made technology, according to a new ...

Calling all Hot Air Balloon enthusiasts! Save the date for the annual Balloons and Tunes Roundup, the third weekend in February. This year we are expecting 40+ Hot Air Balloon Pilots and bands. We are ...

In the current report, we present 24 patients with intrahepatic bile duct dilation and no mass lesion demonstrated on US or CT who underwent resectional treatment under the diagnosis of presumed ...

Achalasia cannot be cured. Instead, our goal is to relieve symptoms, improve esophageal emptying and prevent the development of megaesophagus. The most successful therapies are pneumatic dilation and ...

ENT reported revenue growth driven primarily by the Acclarent acquisition. Total reported revenues for the full-year 2024 were $1,610.5 million, an increase of 4.5%, from the prior year. Organic sales ...

ENT reported revenue growth driven primarily by the Acclarent acquisition. Tissue Technologies (29% of Revenue) Total revenues were $128.0 million, representing an increase of 2.1% on a reported ...

Successful integration of the Acclarent acquisition contributed significantly to revenue growth, particularly in the ENT segment, which experienced substantial growth of 321.6% year-over-year.